AhR is known to activate several signaling pathways governing proliferation, epithelial–mesenchymal transition (EMT), cell migration, inflammation, immunity, and angiogenesis in cancers [12,15,17,18,19,20,21,22,23]. The gene discussed is AHR; the disease is cancer.